Navigation Links
Lilly Announces Significant Global Insulin Manufacturing Capacity Investments in Response to Growing Diabetes Epidemic
Date:11/14/2013

INDIANAPOLIS, Nov. 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it will invest more than $700 million to enhance its global insulin manufacturing capacity in Puerto Rico, France and China, as well as in Indianapolis, home to Lilly's global headquarters. Today's news raises Lilly's manufacturing commitment in the past year to more than $1 billion in planned investments in response to the growing diabetes epidemic and increasing demand for insulin around the world.

Nearly half of the $1 billion investment will improve Indianapolis sites, where Lilly has been manufacturing insulin since it introduced the first commercially available insulin product in 1923.

According to the International Diabetes Federation (IDF)—which today released the latest diabetes prevalence numbers—diabetes is a significant and growing global problem, with high and increasing costs to society and to individuals. The IDF also noted that all types of diabetes are on the rise, with the number of people with type 2 diabetes increasing most dramatically.[i]

"Insulin is a cornerstone of diabetes treatment and its use will only continue to increase given the rising number of people with diabetes around the world," said Enrique Conterno, senior vice president and president, Lilly Diabetes. "Since introducing the first commercially available insulin 90 years ago, Lilly has helped address the global diabetes burden, and today's announcement further underscores our deep commitment to diabetes care."

In addition to committing to investments in manufacturing, the company is investing heavily in diabetes research. Lilly currently has 14 new molecu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medtronic, Lilly Diabetes Join Together as First Ever National Presenting Sponsors of the JDRF Walk To Cure Diabetes
2. Lilly announces Tapiero retiring; Zulueta promoted to senior vice president and president of Emerging Markets
3. Lilly Reports Third-Quarter 2013 Results
4. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
5. Lilly Declares Fourth-Quarter 2013 Dividend
6. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
7. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
8. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
9. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
10. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
11. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 Research and ... of the "Investigation Report on China,s Progesterone ... The clinical demand for steroid drug is ... good efficacy especially its extended use in regulating ... years. Progesterone, a natural progestogen produced by ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Investigation Report on China,s Raloxifene Market, 2010-2019" ... the statistics, over 200 million people suffer from osteoporosis ... in China , 50% have low ... among women aged 60 and above. Raloxifene (raloxifene ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/sd9xxh/radiology ) ... Systems Market by Type, Deployment Mode, End User and ... report to their offering. The ... Million 2014, and is projected to reach $722.7 Million ... to 2019. The global radiology information ...
Breaking Medicine Technology:China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Raloxifene Market, 2015-2019 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3
... Boston Scientific,Corporation (NYSE: BSX ) ... COGNIS(TM),cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM),implantable ... platforms to treat heart failure and sudden ... multi-year research and development effort to provide,physicians ...
... CeloNova BioSciences, Inc.,("CeloNova"), leading and accelerating healthcare ... today announced breakthrough,results from the ATLANTA study ... Polyzene(R)-F at the 20th Annual International Symposium ... ), Corrado Tamburino, MD, President ...
Cached Medicine Technology:Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 2Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 3Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 4CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F 2
(Date:9/3/2015)... ... September 03, 2015 , ... ... for LANDESK Management Suite customers, as part of the LANDESK One Partner ... IT, by delivering the best mobile user experience in remote access and control:, ...
(Date:9/3/2015)... ... 2015 , ... Advice columnist, professional life coach and entrepreneur ... Wasting Your Time Blaming Others for Your Life.” , Released just in time ... obstacles by taking full responsibility for one’s life shares 15 important life lessons ...
(Date:9/3/2015)... ... 03, 2015 , ... Girl’s Night Out to benefit Core Compassion Project will ... Kate Road in Monroe, North Carolina. The event food will be provided ... Kate Clyde’s offers off-premise catering and event services from casual to elegant. They are ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private companies ... "only a tiny fraction of the nation's companies have demonstrated such remarkably consistent ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief executive ... top executive search firms in the healthcare industry, B. E. Smith has recently ...
Breaking Medicine News(10 mins):Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... Solutions , , HOUSTON, June 5 The ... for seniors, with over 500,000 members, has established two ... Retirement Planning. , , These two new divisions ... members, with the goal of better educating and empowering ...
... ... Harley Street based clinic - The London Clinic. The contract marks the world,s first live ... ... , a leading provider of clinical workflow and integration technology for the health care sector ...
... ... the privacy minded individual. , ... London, England (PRWEB) June 5, 2009 -- Best Pills Inc is proud ... bestpills.co.uk., , ,The site is unique in its offering of popularly prescribed "discreet" ...
... Inc. (NYSE: NUS ) today announced the board ... share, which will be paid on June 25, 2009, to ... The Company , For 25 years, Nu Skin ... its comprehensive anti-aging product portfolio, independent business opportunity and corporate ...
... Ortho Biotech Oncology Research & Development, a unit ... it has entered into a five-year Cooperative Research and ... with Steven A. Rosenberg, M.D., Ph.D., chief, Surgery Branch, ... develop novel cell therapy technologies as potential treatments for ...
... Pennsylvania, June 4 , ... Australian Sponsored,Publication Practices From 2000-2005 , ... scientific, technical and,medical (STM) information products and services, ... guidelines for its pharmaceutical services,divisions when producing reprints, ...
Cached Medicine News:Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bestpills Launchs its New Online Pharmacy 2Health News:Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 2Health News:Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 3Health News:Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 4Health News:Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications 2Health News:Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications 3
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... cardiac markers are available on ... Cardiac Troponin I (cTnI) is ... sensitivity and specificity for myocardial ... soon following AMI. CK-MB (mass) ...
... For the quantitative determination of myoglobin concentration ... ELISA test is based on the principle ... The assay system utilizes a unique monoclonal ... on the myoglobin molecule. Mouse monoclonal anti-myoglobin ...
Prolactin Radioimmunoassay...
Medicine Products: